UniProt/SwissProt ID: | TENA_HUMAN |
Description: | tenascin C [Source:HGNC Symbol;Acc:5318] |
Location: | chr9 q33.1 |
Node attribute: | PPI(source) |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
Y2070 | TAQGQyELRVD | Fibrinogen_C | PhosphoSitePlus |
T1902 | EVQSEtALLTW | fn3 | PhosphoSitePlus |
S1020 | YRLNYsLPTGQ | fn3 | PhosphoSitePlus |
Y1418 | YRVSIyGVIRG | fn3 | PhosphoSitePlus |
T1007 | TLLWKtPLAKF | fn3 | PhosphoSitePlus |
T1751 | PITGGtPSMVT | fn3 | PhosphoSitePlus |
T1701 | GRRSQtVSAIA | PhosphoSitePlus | |
T1906 | ETALLtWRPPR | HPRD | |
T1878 | PQKSStITAKF | PhosphoSitePlus | |
T1492 | SGAERtAHISG | fn3 | PhosphoSitePlus |
T1906 | ETALLtWRPPR | fn3 | PhosphoSitePlus |
T2134 | TDSAItNCALS | Fibrinogen_C | PhosphoSitePlus |
T1760 | VTVDGtKTQTR | fn3 | PhosphoSitePlus |
S1703 | RSQTVsAIATT | PhosphoSitePlus | |
Y491 | VCDDGyTGEDC | EGF_2 | PhosphoSitePlus |
S1889 | TTDLDsPRDLT | fn3 | PhosphoSitePlus |
T1885 | TAKFTtDLDSP | PhosphoSitePlus | |
Y1019 | RYRLNySLPTG | fn3 | PhosphoSitePlus |
S72 | DLESAsGEKDL | PhosphoSitePlus; HPRD | |
T1902 | EVQSEtALLTW | HPRD | |
T1842 | KVPEItRTVSG | fn3 | PhosphoSitePlus |
S1846 | ITRTVsGNTVE | fn3 | PhosphoSitePlus |
T1502 | GLPPStDFIVY | fn3 | PhosphoSitePlus |
T1023 | NYSLPtGQWVG | fn3 | PhosphoSitePlus |
T800 | LKRVTtTRLDA | PhosphoSitePlus | |
S1699 | SKGRRsQTVSA | fn3 | PhosphoSitePlus |
T2129 | TFDKDtDSAIT | Fibrinogen_C | PhosphoSitePlus |
T1844 | PEITRtVSGNT | fn3 | PhosphoSitePlus |
Dephosphorylation site |
TENA_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000265131 | M1782T | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000265131 | S70L | COSMIC | Head and Neck Cancer | 21984974 |
ENSP00000345861 | R322W | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
ENSP00000265131 | N297S | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000265131 | G892D | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000344555 | M1236T | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000344400 | R322W | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
ENSP00000344555 | R322W | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
ENSP00000265131 | R499H | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000344555 | N297S | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000265131 | E1897K | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000345861 | M1145T | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000344555 | K942N | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000345861 | N297S | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000265131 | K942N | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000265131 | D644E | COSMIC | Skin Cancer | 21984974 |
ENSP00000265131 | Y779F | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000344400 | N297S | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000265131 | E970K | COSMIC | Melanoma | 21499247 |
ENSP00000344400 | M1418T | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000344400 | K942N | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000265131 | R322W | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
ENSP00000265131 | A738T | COSMIC | Central Nervous System Neoplasms | 18772396 |
ENSP00000345861 | K942N | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000265131 | S1157F | COSMIC | Head and Neck Cancer | 21798897 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000345861 | Oral Cancer | Normal vs. Cancer | tissue | Up | 66 | 19297561 |
ENSP00000345861 | Ovarian Cancer | Metastasis | cell line | Down | 0.23 | 17892554 |
Hyperphosphorylation site |
TENA_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
TENA_HUMAN | SDC1_HUMAN | other | KEGG |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa04512 | ECM-receptor interaction |
hsa04510 | Focal adhesion |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0007528 | neuromuscular junction development | IEA | biological_process |
GO:0010628 | positive regulation of gene expression | IEA | biological_process |
GO:0005614 | interstitial matrix | IEA | cellular_component |
GO:0005604 | basement membrane | IEA | cellular_component |
GO:0060740 | prostate gland epithelium morphogenesis | IEA | biological_process |
GO:0045545 | syndecan binding | IPI | molecular_function |
GO:0031012 | extracellular matrix | IDA | cellular_component |
GO:0060739 | mesenchymal-epithelial cell signaling involved in | IEA | biological_process |
GO:0005615 | extracellular space | IDA | cellular_component |
GO:0005102 | receptor binding | IEA | molecular_function |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0005576 | extracellular region | TAS | cellular_component |
GO:0009611 | response to wounding | IEP | biological_process |
GO:0007155 | cell adhesion | IEA | biological_process |
GO:0005576 | extracellular region | IEA | cellular_component |
GO:0007165 | signal transduction | IEA | biological_process |
GO:0008284 | positive regulation of cell proliferation | IEA | biological_process |
GO:0014012 | peripheral nervous system axon regeneration | IEA | biological_process |